The size of the North America Thrombectomy Devices Market was valued at USD 0.41 billion in 2022. It is further estimated to be growing at a CAGR of 7.9% and worth USD 0.60 billion by 2027.
The Thrombectomy Devices procedures which are commonly used are balloon embolectomy, aspiration embolectomy, and surgical embolectomy. In the aspiration embolectomy procedure, the thrombus is taken out by using suction instead of a balloon. It is thought of as a quick and effective way of removing thrombi in limb arteries. In the Balloon embolectomy, the catheter is inserted, which has an inflatable balloon at its tip. It is inserted into a blood clot and inflated, and then the balloon is removed along with the clot. Risks involved in the procedure are intimal lesions, which can lead to another thrombosis. Surgical embolectomy removes the clot by surgical incision into an artery.
The driving factors of the North America Thrombectomy Devices market are increasing demand for minimally invasive procedures, increasing prevalence of cardiovascular diseases, rising sedentary lifestyle, growing geriatric population, and technological innovations in the medical field. The constraints faced by this market are difficulty in using new equipment, lack of skilled workers, and lack of awareness about peripheral vascular diseases.
This research report on the North America Thrombectomy Devices Market has been segmented and sub-segmented into the following categories:
By Type:
By Application:
By End Users:
By Disease:
By Country:
Geographically, the largest share is recorded by the United States in the region, which can be owed to many technologically advanced devices present in the country. Factors such as the rising geriatric population, increased incidence of cardiovascular diseases, and technological advancements in the medical field are expected to drive the market growth in the region.
Promising Companies dominating the North America Thrombectomy Devices Market Profiled in the Report are Stryker Corporation (U.S.), Medtronic Plc (U.S.), Boston Scientific Corporation (U.S.), Penumbra, Inc. (U.S.) Johnson & Johnson (U.S.), Terumo Corporation (Japan), Spectranetics Corporation (U.S.), Edwards Lifesciences Corporation (U.S.), Argon Medical Devices, Inc. (U.S.), and Teleflex Incorporated (U.S.).
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Type
5.1.1 Stent Retrievers
5.1.2 Basket/Brush Retrievers
5.1.3 Coil Retrievers
5.1.4 Mechanical Thrombectomy Devices
5.1.4.1 Stent Retrievers
5.1.4.2 Coil Retrievers
5.1.4.3 Basket/Brush Retrievers
5.1.5 Ultrasonic Thrombectomy Devices
5.1.6 Aspiration Thrombectomy Devices
5.1.7 Hydrodynamic Thrombectomy Devices
5.1.8 Y-o-Y Growth Analysis, By Type
5.1.9 Market Attractiveness Analysis, By Type
5.1.10 Market Share Analysis, By Type
5.2 Application
5.2.1 Peripheral Vascular Application
5.2.2 Neurovascular Application
5.2.3 Cardiovascular Application
5.2.4 Y-o-Y Growth Analysis, By Application
5.2.5 Market Attractiveness Analysis, By Application
5.2.6 Market Share Analysis, By Application
5.3 End-Users
5.3.1 Research Laboratories & Academic Institutes
5.3.2 Ambulatory Surgical Centres
5.3.3 Hospital Surgical Centres
5.3.4 Other end-users
5.3.5 Y-o-Y Growth Analysis, By End-Users
5.3.6 Market Attractiveness Analysis, By End-Users
5.3.7 Market Share Analysis, By End-Users
5.4 Diseases
5.4.1 Coronary Diseases
5.4.2 Neural Diseases
5.4.3 Peripheral Diseases
5.4.4 Y-o-Y Growth Analysis, By Diseases
5.4.5 Market Attractiveness Analysis, By Diseases
5.4.6 Market Share Analysis, By Diseases
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Type
6.1.3.2 By Application
6.1.3.3 By End-Users
6.1.3.4 By Diseases
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Type
6.1.4.2 By Application
6.1.4.3 By End-Users
6.1.4.4 By Diseases
6.1.5 Market Share Analysis
6.1.5.1 By Type
6.1.5.2 By Application
6.1.5.3 By End-Users
6.1.5.4 By Diseases
6.2 United States
6.3 Canada
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Stryker Corporation
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Medtronic Plc
8.3 Boston Scientific Corporation
8.4 Penumbra, Inc.
8.5 Johnson & Johnson
8.6 Terumo Corporation
8.7 Spectranetics Corporation
8.8 Edwards Lifesciences Corporation
8.9 Argon Medical Devices, Inc.
8.10 Teleflex Incorporated
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
Talk to our analyst and get customised report done according to your research needs
Check if you can avail any discount. Submit your details and our team will get back to you.
Request to avail a free sample report that reflects this market and its growth.
